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1 Example of fragment enrichment analysis on a drug dataset
In order to present a proof-of-principle application of the molBLOCKS suite, we performed
fragmentation and enrichment analysis on antineoplastic drugs, highlighting the statisti-
cally enriched fragments.
1.1 Dataset preparation
We collected all the drugs deposited in the KEGG DRUG Database[1, 2] (10,037 molecules).
Of these, we selected the drugs that had at least one ATC (Anatomical Therapeutic Chem-
ical Classification System) code, resulting in 4,581 molecules. Then, we filtered these com-
pounds by molecular weight ( 900 Daltons), obtaining the final background set of 3,685
small molecules. Antineoplastic drugs were extracted from the background set by selecting
all the molecules annotated with the ATC code L01 (“antineoplastic agents”), resulting in
165 drugs.
1.2 Fragmentation
Both the background set and the antineoplastic set were fragmented using the fragment
program with the RECAP rules[3], a minimum fragment size of 4 and the extensive frag-
mentation flag on. Extensive fragmentation ensures that all possible fragments are combi-
natorially generated whenever the bonds that match the rules cannot be cleaved all at the
same time (please see the User’s Guide for more details on the algorithm).
⇤Lewis-Sigler Institute For Integrative Genomics, Princeton University, Princeton, NJ 08544 USA
†Department of Computer Science, Princeton University, Princeton, NJ 08544 USA
1
Figure 1: Fragment 2 – The representative fragment for the second cluster is shown in the left
panel, and drugs that contain a fragment in this cluster are shown in the right panel.
The enriched fragment corresponds to chlormethine (minus the methyl group), the pro-
totype drug of the nitrogen mustard alkylating agents, the class to which all the other
compounds shown here belong.
1.3 Enrichment analysis
The analyze program was used to perform enrichment analysis on the antineoplastic set,
clustering the fragments at a Tanimoto similarity of 0.8. Four clusters of fragments found
to be significantly enriched (FDR <= 0.001) and together occurring > 5 times in the main
set are highlighted in Figure 2 in the main text and Figures 1-3 here. We note that the
analyze program found 2 additional enriched clusters that correspond to full molecules
(i.e., they could not be fragmented according to the rules used), and 1 additional enriched
cluster whose fragments overlapped those of one of the four main clusters (due to extensive
fragementation). For convenience, these are not shown here.
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Figure 2: Fragment 3 – All the compounds shown in the right panel are nucleosides, which act by
mimicking DNA nucleobases, and interfere with DNA synthesis. The enriched fragment
is the sugar moiety of the bases.
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Figure 3: Fragment 4 – The molecules shown here are all kinase inhibitors, and while di↵erent
from each other at the global level, all share a heterocyclic aromatic nitrogen compound
with a double-ring structure (quinoline). Quinoline has recently been called a “privi-
leged” sca↵old in cancer drug discovery [4].
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